Related Experiment Video
Updated: Sep 13, 2025
07:41
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
14.2K
A Practical Guide to Behavioral Treatment for Children with Disorders of Gut-Brain Interaction
Jessica Buzenski1, Stephanie Davenport2, Amanda Glinky3
1Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Gastroenterology Clinics of North America
|August 2, 2025
Summary
Disorders of Gut-Brain Interaction (DGBI) significantly impact children
Area of Science:
- Pediatric Gastroenterology
- Neurogastroenterology
- Child Psychology
Background:
- Disorders of Gut-Brain Interaction (DGBI) are prevalent in children.
- These conditions significantly affect the quality of life for both children and their caregivers.
- Current management often requires a comprehensive approach.
Purpose of the Study:
- To highlight the importance of a biopsychosocial approach in managing pediatric DGBI.
- To emphasize treatments targeting the gut-brain axis.
- To advocate for improved access and acceptance of specialized care.
Main Methods:
- Screening for biological and environmental triggers.
- Implementing treatments focused on the gut-brain axis.
- Utilizing a psychogastroenterology specialist model.
Main Results:
- Biopsychosocial interventions targeting the gut-brain axis show significant symptom improvement.
- Specialized care can lead to better outcomes for various gastrointestinal diseases.
- The approach addresses the complex interplay of factors in DGBI.
Conclusions:
- A biopsychosocial framework is essential for treating pediatric DGBI.
- Gut-brain axis-targeted therapies offer substantial benefits.
- Increased acceptance and accessibility of psychogastroenterology are crucial for advancing care.
Related Concept Videos
01:24Operant Conditioning Intervention
114
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
114
01:22Behavior Therapy
110
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
110
01:21Behavior Modification
236
Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
A real-world application of operant conditioning principles is applied...
236
01:17Drugs for Treatment of Diarrhea-Predominant IBS
294
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
294
01:17Irritable Bowel Syndrome I: Introduction
388
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
388
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
303
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
303